Dynamic focal adjustment technology is currently in the laboratory research phase, which is why neither a market release date nor a final price for the device has been determined. Solutions being worked on by companies such as Mojo Vision or Innovega remain the subject of intensive research, rather than finished products available to patients in optical salons. The prospect of replacing progressive glasses with variable-focus contact lenses remains a challenge, where materials engineering clashes with the hard reality of human physiology.
Mechanism of action: how does the lens adjust focus?
The foundation of the new technology is a move away from rigid lenses with fixed geometry toward advanced polymers with a variable refractive index. Engineers from academic centers, such as the Massachusetts Institute of Technology (MIT), are exploring the possibility of using electroactive materials that respond to external stimuli without the need for massive mechanisms to move lens components. This departure from hard mechanical components is crucial for user comfort. The lens must remain soft and flexible so as not to impose an unnatural center of gravity on the eye, which, in the case of hard prototypes with electronics, leads to rapid corneal fatigue.
The mechanism itself is based on the material's precise reactivity to a signal. In projects like those being developed by Mojo Vision, the vision involves an integrated micro-lens display or an active layer that changes its optical power in response to an electrical impulse. Instead of forcing a change in physical shape through external forces, which would be dangerous for the eye, the system is intended to mimic natural accommodation. When a user shifts their gaze from a distant object to text on a smartphone, a sensor should detect the change in the focal point and initiate a change in the polymer's optical properties. In this way, the eye receives a sharp image without the need for excessive work by the ciliary muscles, which lose their elasticity in the case of presbyopia.
In theory, this sounds like a solution to the problems faced by users of progressive glasses. In practice, however, every prototype that leaves the sterile laboratory environment encounters a power supply problem. Current laboratory models do not offer operating times comparable to daily disposable lenses. Engineering estimates suggest that for the system to be useful, it would need to have a cell with a capacity allowing for at least 12-16 hours of operation without charging, which is impossible with current micro-scale battery sizes. The failure of prototype creators to provide a specific capacity in mAh clearly indicates that the energy balance problem has not yet been solved. The user will not receive a finished product until a method of wireless energy transmission is developed that does not overheat the eye tissue.
Who will be most interested in this solution?
The main beneficiaries of dynamic lenses are intended to be people struggling with presbyopia, which is the natural aging process of the eye. This phenomenon affects almost every person over the age of 40, when the eye's lens becomes stiffer and the ciliary muscles less efficient. Currently, the only proven method of correction is progressive glasses, which divide the lens into zones of different power. This forces the patient to move their head in a specific way to hit the zone of sharp vision.
The technologies being developed, such as those supported by Innovega as part of the iOptik system, aim to eliminate the "swimming" effect of the image, which is the bane of progressive lens users. For people with strong vision defects, the need to constantly juggle reading and walking glasses is a burden that cannot be fully eliminated even by the most expensive "individual" lenses. Dynamic lenses promise a smooth transition between different distances, which in theory restores the visual comfort known from youth.
However, enthusiasm must be tempered by the lack of clinical data. Technology enthusiasts often forget that the change in focus in milliseconds, controlled by an algorithm, must be perfectly synchronized with the movement of the eyeballs. If the delay between eye movement and lens reaction is more than a few milliseconds, the user may experience dizziness and nausea, similar to those caused by poorly calibrated VR goggles. This is not just a software problem, but primarily a neurological one. The brain must accept a new way of perceiving image depth, which for many patients may prove to be an insurmountable barrier.
Prospects for the application of this solution include:
- Precise support for people with presbyopia through automatic focus adaptation in real time.
- Flexibility in daily tasks requiring rapid focal length changes, such as working at a computer alternating with driving a vehicle.
- Elimination of the need to carry several pairs of glasses with different powers, which will significantly affect daily convenience.
- Increased psychological comfort for patients for whom the need for constant use of optical correction is an image or functional burden.
The lack of a specific implementation schedule means that for now, we remain in the realm of laboratory tests. Verification of this technology in clinical conditions and daily use, in accordance with medical guidelines, is still ahead of us.
Comparison: dynamic lenses vs. traditional progressive glasses
Traditional progressive glasses have dominated the presbyopia correction market for years, but their construction imposes a number of physical limitations on the user. The main drawback is the narrowing of the field of view in intermediate and peripheral zones. This forces the patient to constantly adapt by precisely positioning their head relative to the object they are looking at. This is not a natural movement of the eyeball, but a learned compensation, which for many people remains an insurmountable barrier. From an optical perspective, every progressive lens is a compromise between the width of the field of view and image distortion.
Dynamic focal length lenses promise to solve this problem by offering a wide field of view that would overlap with the natural movement of the eye. Instead of looking for the right point in the lens, the gaze simply follows the object. Theoretically, we eliminate the image swimming effect and the need to constantly turn the head. However, it should be remembered that current progressive glasses are the result of decades of refining lens geometry, while dynamic lenses have not yet moved beyond the laboratory prototype stage.
Below is a summary of parameters illustrating the current state of knowledge about both technologies:
- Progressive glasses — limited field of vision (documented optical data).
- Progressive glasses — necessity of adapting head movements (confirmed by ophthalmological studies).
- Dynamic lenses — potentially wide field of view (data from the laboratory research phase).
- Dynamic lenses — no data on durability (lack of long-term studies).
- Dynamic lenses — no official market release date (as of current knowledge).
- Dynamic lenses — no established final price (as of current knowledge).
The key catch lies in durability and chemical safety. Glasses, despite their flaws, are a proven product. We know how they behave after a year of wearing, how they handle scratches or temperature changes. In the case of dynamic lenses, which contain advanced electronics or polymers that react to impulses, we do not have any data regarding their lifespan. If this technology is actually to replace proven methods, it must prove that it will not fail the user after a few months of daily use. The manufacturer has not stated how the system will handle protein deposits that naturally accumulate on the surface of contact lenses. Will the electronics be able to work under a layer of deposits? This question remains unanswered.
Engineering challenges: barriers on the road to commercialization
Work on dynamic focal length lenses is stuck in laboratories, and the list of technical problems that engineers must solve remains long and exhausting. The most serious barrier remains ensuring full long-term biocompatibility of materials. The eye is an extremely demanding environment, full of enzymes and salts that can degrade even the most advanced polymers. Long-term contact with materials capable of changing shape under the influence of an electrical impulse raises legitimate concerns about corneal irritation.
The next point is pure mechanics. The lens must withstand thousands of focal change cycles per day, working flawlessly over a service life measured in months. Any micro-crack in the structure or material fatigue in such a delicate element means not only equipment failure but a direct threat to the user's eyesight. Material durability while maintaining flexibility is a tough nut to crack for materials scientists. In laboratories, lenses are tested in accelerated cycles, but simulation will not replace the real environment of the eye, where blinking, changes in tear film pH, and fluctuations in eye surface temperature occur.
The issue of power supply and chemical stability of the control system has also not been solved. Laboratory models require external power sources or complex control systems, which on the microscopic scale of a contact lens is an engineering challenge of the highest degree of difficulty. The manufacturer has not provided information on how the problem of inductive charging through the eyelid was solved. Will a miniature battery be safe? How to ensure the tightness of the system so that tear fluid does not react with the electronics? Answers to these questions still remain in the realm of theoretical assumptions, not finished prototypes.
From the perspective of the "Wiadomości PRO" editorial team, we must temper the optimism. Promises of replacing progressive glasses remain in the realm of futuristic visions. Until these engineering barriers are overcome in controlled conditions, there can be no talk of mass production. For now, it is a safer laboratory experiment for the user, which does not yet have its equivalent on a store shelf.
Safety and medical standards
The introduction of lenses with dynamic focal adjustment to the market will not be a formal path for typical electronic gadgets. This is a Class III medical device, which means the most restrictive certification procedures. Regulatory bodies, such as notified bodies in the European Union or the American FDA, require manufacturers to provide full evidence that the device does not threaten the patient's health in any usage scenario. Currently, this technology is only in the laboratory research phase, which automatically excludes the existence of a market release date or any final price.
In ophthalmic optics, the foundation is the health of the cornea, and here oxygen permeability standards, known as the Dk/t parameter, become crucial. Any material that has direct contact with the eye for several hours a day must ensure adequate gas diffusion. In the case of dynamic polymers that are to physically change their shape or optical properties, scientists are still facing the challenge of maintaining high oxygen permeability while ensuring the mechanical stability of the lens. If the material is too thick to accommodate the electronics, oxygen permeability will drop, leading to corneal hypoxia and the development of inflammation.
However, the most important piece of the puzzle is missing: long-term clinical trials. The side effects resulting from the long-term use of dynamic polymers have not yet been confirmed. Even if prototypes in laboratories work flawlessly, the transition from the "works in controlled conditions" phase to "is safe for the population" takes years. Patients with vision defects must therefore arm themselves with patience. Technological optimism must give way to biochemical verification. For now, it is a promise, not a product that could reach an ophthalmologist's office in the near future.
Market prospects: what are we waiting for?
Dynamic focal adjustment technology remains locked today in the sterile conditions of laboratories, which effectively cools the enthusiasm of opticians and potential patients. Despite the enthusiastic announcements of engineers, the market reality is much more prosaic than media visualizations. We are not dealing with a product that will soon hit the shelves of optical salons, but with a project that is still looking for answers to fundamental questions about the safety of long-term use by humans.
Industry expectations are dashed by the lack of specifics. Investors and potential users ask the same questions, to which manufacturers remain deaf or reticent in communication. The state of advancement of the project currently boils down to several unknowns, which are crucial for every consumer:
- Lack of any publicly available implementation schedule for sale, which makes it impossible to even roughly estimate the debut of the device.
- A complete lack of official information about the unit price, which makes debates about price accessibility purely theoretical considerations at this stage.
- The necessity of conducting extensive clinical trials on control groups, without which the product will not receive the necessary medical certificates allowing it for sale.
The truth is that this technology must go a long way from a prototype to a medical device. Focusing solely on the technical capabilities of the lenses obscures the fact that there is a lack of transparent data regarding the long-term impact of focusing mechanisms on the cornea of the eye. Until this data is published, the entire discussion about market dominance over progressive glasses remains in the realm of academic forecasts. The optical industry does not like an information vacuum, but in this case, patience is the only available currency, because no one will risk putting an unrefined device on sale that could permanently damage the user's eyesight.
What this means for you
For patients, this is a chance to regain natural visual comfort without having to reach for glasses. However, as an editorial team, we must warn against excessive optimism. This technology is in the early research phase, and the road to a commercial medical device is expensive and fraught with high risk of failure in clinical trials. If your vision defect requires correction, rely on methods proven in an ophthalmologist's office.
Questions and answers
Are these lenses already available in optical offices?
No, the technology is currently in the laboratory research phase and is not available for commercial sale. No manufacturer has confirmed a date for introducing the device to the market.
What vision defects will these lenses correct?
The main goal is to help people with presbyopia (age-related farsightedness). Potentially, they could also support other defects requiring variable focal length, however, current work focuses on compensating for the loss of the eye's natural accommodation.
Do we know the price of such lenses?
No, due to the early stage of work on the technology, no market prices or unit costs have been set. Any speculation regarding the price is premature at this moment.
Will this solution replace progressive glasses?
This is the declared goal of the manufacturers, however, at the current stage, this technology is only a research project. Progressive glasses remain the medical standard until dynamic lenses undergo years of safety tests and are registered as a medical device.
Article prepared by the Wiadomości PRO editorial team with the support of artificial intelligence. Facts come from the sources provided above.
Komentarze (0)
Ładowanie komentarzy...